LifeVantage to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Rhea-AI Summary
LifeVantage (Nasdaq: LFVN), a leading health and wellness company, has announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference. The event is scheduled for September 9-11, 2024 in New York, NY. Steve Fife, President and CEO, and Carl Aure, CFO, will represent the company, meeting with investors and delivering a presentation on Tuesday, September 10, 2024, at approximately 2:00 p.m. Eastern Time.
A live webcast of the presentation will be available on the company's Investor Relations website. The webcast replay will be accessible for about 90 days after the event. This conference participation highlights LifeVantage's commitment to engaging with investors and showcasing its products designed to activate optimal health processes at the cellular level.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, LFVN gained 2.51%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
SALT LAKE CITY, Sept. 04, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the H.C. Wainwright 26th Annual Global Investment Conference, to be held September 9-11, 2024 in New York, NY.
Mr. Fife and Mr. Aure will meet with investors and present at approximately 2:00 p.m. Eastern Time on Tuesday, September 10, 2024. A live webcast of their presentation will be accessible on the News & Events section of the Company’s Investor Relations website at https://lifevantage.gcs-web.com/ or directly here. A replay of the webcast will be archived and can be accessed for approximately 90 days on the Company’s website.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq: LFVN), the activation company, is a pioneer in nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and probiotics, weight management, and skin and hair care products. The Company’s line of scientifically-validated dietary supplements includes its flagship Protandim® family of products, LifeVantage® Omega+, ProBio, IC Bright®, Daily Wellness, Rise AM, Reset PM, and D3+ dietary supplements, the TrueScience® line of skin and hair care products and Liquid Collagen. The Company also markets and sells Petandim®, its companion pet supplement formulated to combat oxidative stress in dogs, and Axio®, its nootropic energy drink mixes. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.
Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com
FAQ
When is LifeVantage (LFVN) participating in the H.C. Wainwright Global Investment Conference?
Who will represent LifeVantage (LFVN) at the H.C. Wainwright conference?
When is LifeVantage's (LFVN) presentation at the H.C. Wainwright conference?
How can investors access LifeVantage's (LFVN) presentation at the H.C. Wainwright conference?
How long will the replay of LifeVantage's (LFVN) presentation be available?
